Tolcapone: A Review of its Use in the Management of Parkinson's Disease

By Gillian M. Keating   Katherine A. Lyseng-Williamson  

CNS Drugs, Vol. 19, Iss. 2, 2005-01 ,pp. : 165-184

Adis International

Access to resources Recommend Favorite

Tolcapone in Parkinson’s disease: liver toxicity and clinical efficacy

By Borges Nuno  

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 69-73

Informa Healthcare

Access to resources Recommend Favorite

Role of Mitochondrial Dysfunction in Parkinson's Disease: Implications for Treatment

By Ramsey Chenere P.   Giasson Benoit I.  

Drugs & Aging, Vol. 24, Iss. 2, 2007-01 ,pp. : 95-105

Adis International

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Relationship of Levodopa with and without Tolcapone in Patients with Parkinson's Disease

By Baas H.  

Clinical Pharmacokinetics, Vol. 40, Iss. 5, 2001-01 ,pp. : 383-393

Adis International

Access to resources Recommend Favorite

Glutamate Antagonists for Parkinson's Disease: Rationale for Use and Therapeutic Implications

By Cooper A.J.  

CNS Drugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 421-429

Adis International

Access to resources Recommend Favorite